BioCentury
ARTICLE | Financial News

Vertex ups Kalydeco guidance

May 1, 2013 12:39 AM UTC

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) reported 1Q13 financial results after market close on Tuesday and raised its 2013 guidance for net revenues of cystic fibrosis (CF) drug Kalydeco ivacaftor to...